Journal
CLINICAL CASES IN MINERAL AND BONE METABOLISM
Volume 13, Issue 2, Pages 131-134Publisher
CIC EDIZIONI INT
DOI: 10.11138/ccmbm/2016.13.2.131
Keywords
hyaluronic acid; osteoarthritis; injections
Categories
Ask authors/readers for more resources
Osteoarthritis (OA) is a chronic degenerative joint disease characterized by pain and progressive functional limitation. Viscosupplementation with intra-articular (IA) hyaluronic acid (HA) could be a treatment option in OA, however recommendations made in different international guidelines for the non-surgical management of OA are not always concordant with regard to the role of IA injection therapies. Results from a recent Italian Consensus Conference underline how IA-HA to treat OA represents a widely used therapy in Italy. Specifically high molecular weight HA, crosslinked HA, and mobile reticulum HA are considered very useful to treat the OA joints from a great number of expert in Italy. These kinds of HA could reduce the NSAIDs intake, furthermore high-molecular weight and mobile reticulum HA are considered to be able to delay or avoid a joint prosthetic implant. This mini review highlights the results obtained from the Italian Consensus Conference Appropriateness of clinical and organizational criteria for intra-articular injection therapies in osteoarthritis and give further indication about innovation in IA-HA therapies.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available